Antibiotic Treatment for Acute Bacterial Sinusitis
Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-7 days is the preferred first-line antibiotic for adults with acute bacterial sinusitis, due to the high prevalence (20-30%) of β-lactamase-producing organisms that render plain amoxicillin ineffective. 1
Confirming the Diagnosis Before Prescribing
Before initiating antibiotics, confirm the patient meets one of three diagnostic criteria for bacterial (not viral) sinusitis 2, 3:
- Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure) 2, 3
- Severe symptoms for ≥3-4 consecutive days: fever ≥39°C with purulent nasal discharge 2, 4
- "Double sickening": worsening symptoms after initial improvement from a viral upper respiratory infection 2, 3
Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics 2. Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present 2, 3.
First-Line Treatment Algorithm
For Adults Without Penicillin Allergy
Standard therapy: Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-7 days 1, 3
High-dose therapy (use if recent antibiotic exposure within past month, age >65 years, comorbid conditions, or immunocompromised): Amoxicillin-clavulanate 2000 mg/125 mg twice daily 2, 3
The clavulanate component provides essential coverage against β-lactamase-producing Haemophilus influenzae (20-30% of cases) and Moraxella catarrhalis (12-28% of cases) 1. Plain amoxicillin is no longer appropriate as first-line therapy 1, 3.
For Pediatric Patients
Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses for 10-14 days 2, 3
High-dose therapy (for age <2 years, daycare attendance, recent antibiotic use, or high local resistance): Amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 2, 1, 3
Penicillin-Allergic Patients
Non-Severe Allergy (Rash, Delayed Reactions)
Second- or third-generation cephalosporins are safe and effective, as the risk of serious cross-reactivity is negligible 2, 1, 3:
- Cefuroxime-axetil (second-generation): 250-500 mg twice daily 5, 2
- Cefpodoxime-proxetil (third-generation): 200-400 mg twice daily 5, 2
- Cefdinir (third-generation): 300 mg twice daily 2, 1
Third-generation cephalosporins provide superior activity against H. influenzae compared to second-generation agents 2.
Severe Type I Hypersensitivity (Anaphylaxis)
Respiratory fluoroquinolones are the treatment of choice 2, 1, 3:
- Levofloxacin 500 mg once daily for 10-14 days 2, 1, 6
- Moxifloxacin 400 mg once daily for 10 days 2, 1
Fluoroquinolones demonstrate 90-92% predicted clinical efficacy and 100% microbiologic eradication of S. pneumoniae, including multi-drug resistant strains 2, 6, 7.
Treatment Failure Protocol
Reassess at 3-5 days (adults) or 72 hours (pediatrics) 2, 1, 3. If no improvement or worsening symptoms:
Switch to high-dose amoxicillin-clavulanate (if not already prescribed): 2000 mg/125 mg twice daily for adults 2, 3
If amoxicillin-clavulanate fails, switch to a respiratory fluoroquinolone 2, 1, 3:
Consider ceftriaxone for patients unable to tolerate oral medications: 1-2 g IM/IV once daily for 5 days (adults) or 50 mg/kg once daily (pediatrics) 2
Antibiotics to AVOID
Never use these agents as first-line therapy for acute bacterial sinusitis:
- Azithromycin and macrolides: Resistance rates exceed 20-25% for both S. pneumoniae and H. influenzae 2, 1, 8, 4
- First-generation cephalosporins (cephalexin): Inadequate coverage against H. influenzae 2
- Clindamycin monotherapy: No activity against H. influenzae or M. catarrhalis 2
- Trimethoprim-sulfamethoxazole: Resistance rates of 50% for S. pneumoniae and 27% for H. influenzae 2
Adjunctive Therapies That Improve Outcomes
Intranasal corticosteroids should be added to antibiotic therapy in all patients 2, 1, 3:
- Mometasone, fluticasone, or budesonide twice daily 2, 3
- Reduces mucosal inflammation and improves symptom resolution 2, 1
Short-term oral corticosteroids (5 days) may be considered for 2:
- Patients who fail initial antibiotic treatment 2
- Marked mucosal edema 2
- Severe pain (acute hyperalgic sinusitis) 2
- Intranasal saline irrigation 2
- Analgesics (acetaminophen, NSAIDs) 2
- Adequate hydration 2
- Warm facial packs 2
Treatment Duration
Adults: 5-7 days for uncomplicated maxillary sinusitis 1, 3. Shorter courses (5-7 days) have comparable efficacy with fewer side effects compared to 10-14 day courses 2, 1, 9.
Pediatrics: 10-14 days or until symptom-free for 7 days 2, 1, 3
Frontal, ethmoidal, or sphenoidal sinusitis: Consider longer duration (10-14 days) due to higher risk of complications 5, 2
When to Refer to a Specialist
Refer to otolaryngology or allergy/immunology for 2:
- Symptoms refractory to two courses of appropriate antibiotics 2
- Recurrent sinusitis (≥3 episodes per year) 2
- Suspected complications: orbital cellulitis, meningitis, severe frontal/sphenoidal sinusitis 5, 2
- Need for sinus aspiration/culture in immunocompromised patients 2
Critical Pitfalls to Avoid
- Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days unless severe symptoms are present 2, 3
- Do not use plain amoxicillin as first-line therapy given high prevalence of β-lactamase-producing organisms 1, 3
- Do not continue ineffective antibiotics beyond 3-5 days—failure to reassess and switch therapy leads to prolonged illness and complications 2, 1, 3
- Do not reserve fluoroquinolones as routine first-line therapy—use only for treatment failures, severe disease, or documented penicillin allergy to prevent resistance 2, 1, 6
- Do not use systemic corticosteroids without antibiotics when bacterial sinusitis is suspected, as this may suppress immune response and allow bacterial proliferation 2